BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27466472)

  • 21. Genetic testing in familial and young-onset Alzheimer's disease: mutation spectrum in a Serbian cohort.
    Dobricic V; Stefanova E; Jankovic M; Gurunlian N; Novakovic I; Hardy J; Kostic V; Guerreiro R
    Neurobiol Aging; 2012 Jul; 33(7):1481.e7-12. PubMed ID: 22221884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network.
    Karch CM; Hernández D; Wang JC; Marsh J; Hewitt AW; Hsu S; Norton J; Levitch D; Donahue T; Sigurdson W; Ghetti B; Farlow M; Chhatwal J; Berman S; Cruchaga C; Morris JC; Bateman RJ; ; Pébay A; Goate AM
    Alzheimers Res Ther; 2018 Jul; 10(1):69. PubMed ID: 30045758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease.
    Ezquerra M; Lleó A; Castellví M; Queralt R; Santacruz P; Pastor P; Molinuevo JL; Blesa R; Oliva R
    Arch Neurol; 2003 Aug; 60(8):1149-51. PubMed ID: 12925374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alzheimer disease: autosomal dominant forms].
    Guyant-Maréchal L; Campion D; Hannequin D
    Rev Neurol (Paris); 2009 Mar; 165(3):223-31. PubMed ID: 19081588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes.
    Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Nordberg A; Viitanen M; Lannfelt L; Graff C
    Neurobiol Aging; 2019 Oct; 82():40-47. PubMed ID: 31386938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and neuroimaging characterization of Chinese dementia patients with PSEN1 and PSEN2 mutations.
    Shi Z; Wang Y; Liu S; Liu M; Liu S; Zhou Y; Wang J; Cai L; Huo YR; Gao S; Ji Y
    Dement Geriatr Cogn Disord; 2015; 39(1-2):32-40. PubMed ID: 25323700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease.
    Sassi C; Guerreiro R; Gibbs R; Ding J; Lupton MK; Troakes C; Lunnon K; Al-Sarraj S; Brown KS; Medway C; Lord J; Turton J; Mann D; Snowden J; Neary D; Harris J; Bras J; ; Morgan K; Powell JF; Singleton A; Hardy J
    Neurobiol Aging; 2014 Oct; 35(10):2422.e13-6. PubMed ID: 24880964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical early-onset Alzheimer's disease caused by the Iranian APP mutation.
    Lindquist SG; Nielsen JE; Stokholm J; Schwartz M; Batbayli M; Ballegaard M; Erdal J; Krabbe K; Waldemar G
    J Neurol Sci; 2008 May; 268(1-2):124-30. PubMed ID: 18187157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epileptic seizures in autosomal dominant forms of Alzheimer's disease.
    Cortini F; Cantoni C; Villa C
    Seizure; 2018 Oct; 61():4-7. PubMed ID: 30041064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and validation of dominantly inherited Alzheimer's disease mutations in populations from Latin America.
    Takada LT; Aláez-Verson C; Burgute BD; Nitrini R; Sosa AL; Castilhos RM; Chaves MF; Longoria EM; Carrillo-Sánchez K; Brucki SMD; Flores-Lagunes LL; Molina C; Olivares MJ; Ziegemeier E; Petranek J; Goate AM; Cruchaga C; Renton AE; Fernández MV; Day GS; McDade E; Bateman RJ; Karch CM; Llibre-Guerra JJ;
    Alzheimers Res Ther; 2022 Aug; 14(1):108. PubMed ID: 35932032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis.
    Ataka S; Tomiyama T; Takuma H; Yamashita T; Shimada H; Tsutada T; Kawabata K; Mori H; Miki T
    Arch Neurol; 2004 Nov; 61(11):1773-6. PubMed ID: 15534188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired default network functional connectivity in autosomal dominant Alzheimer disease.
    Chhatwal JP; Schultz AP; Johnson K; Benzinger TL; Jack C; Ances BM; Sullivan CA; Salloway SP; Ringman JM; Koeppe RA; Marcus DS; Thompson P; Saykin AJ; Correia S; Schofield PR; Rowe CC; Fox NC; Brickman AM; Mayeux R; McDade E; Bateman R; Fagan AM; Goate AM; Xiong C; Buckles VD; Morris JC; Sperling RA
    Neurology; 2013 Aug; 81(8):736-44. PubMed ID: 23884042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.
    Ringman JM; Monsell S; Ng DW; Zhou Y; Nguyen A; Coppola G; Van Berlo V; Mendez MF; Tung S; Weintraub S; Mesulam MM; Bigio EH; Gitelman DR; Fisher-Hubbard AO; Albin RL; Vinters HV
    J Neuropathol Exp Neurol; 2016 Mar; 75(3):284-90. PubMed ID: 26888304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presenilin-1 mutation Alzheimer's disease: a genetic epilepsy syndrome?
    Larner AJ
    Epilepsy Behav; 2011 May; 21(1):20-2. PubMed ID: 21501974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.
    Lee S; Viqar F; Zimmerman ME; Narkhede A; Tosto G; Benzinger TL; Marcus DS; Fagan AM; Goate A; Fox NC; Cairns NJ; Holtzman DM; Buckles V; Ghetti B; McDade E; Martins RN; Saykin AJ; Masters CL; Ringman JM; Ryan NS; Förster S; Laske C; Schofield PR; Sperling RA; Salloway S; Correia S; Jack C; Weiner M; Bateman RJ; Morris JC; Mayeux R; Brickman AM;
    Ann Neurol; 2016 Jun; 79(6):929-39. PubMed ID: 27016429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene mutations associated with early onset familial Alzheimer's disease in China: An overview and current status.
    Qin Q; Yin Y; Wang Y; Lu Y; Tang Y; Jia J
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1443. PubMed ID: 32767553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel PSEN2 p.Ser175Phe variant in a family with Alzheimer's disease.
    Guven G; Samanci B; Gulec C; Hanagasi H; Gurvit H; Gokalp EE; Tepgec F; Guler S; Uyguner O; Bilgic B
    Neurol Sci; 2021 Jun; 42(6):2497-2504. PubMed ID: 33855622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations.
    Scahill RI; Ridgway GR; Bartlett JW; Barnes J; Ryan NS; Mead S; Beck J; Clarkson MJ; Crutch SJ; Schott JM; Ourselin S; Warren JD; Hardy J; Rossor MN; Fox NC
    J Alzheimers Dis; 2013; 35(1):199-212. PubMed ID: 23380992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease.
    Brouwers N; Sleegers K; Engelborghs S; Bogaerts V; Serneels S; Kamali K; Corsmit E; De Leenheir E; Martin JJ; De Deyn PP; Van Broeckhoven C; Theuns J
    Brain; 2006 Nov; 129(Pt 11):2984-91. PubMed ID: 16931535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mutation screening by DHPLC of PSEN1 and APP genes reveals no significant variation associated with the sporadic late-onset form of Alzheimer's disease.
    Scacchi R; Gambina G; Moretto G; Corbo RM
    Neurosci Lett; 2007 May; 418(3):282-5. PubMed ID: 17412506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.